TABLE 2.
MICs (determined by Etest) of several β-lactam and non-β-lactam antibiotics for the epidemic CTX-M-1-producing multiresistant K. pneumoniae strain, the two carbapenem-resistant mutants, and the E. coli transformant harboring the CTX-M-1-encoding plasmid pAMR-1
Antibiotic | MIC (μg/ml) for:
|
||||
---|---|---|---|---|---|
CTX-M-1-producing K. pneumoniae epidemic straina |
K. pneumoniae carbapenem-resistant mutants
|
E. coli XL1-Blue | E. coli XL1-Blue (pAMR-1) | ||
KpCR-1 | KpCR-2 | ||||
Ampicillin | >256 | >256 | >256 | 4 | >256 |
Amoxycilin + clavulanate | 16-32 | >256 | 32 | 4 | 16 |
Ticarcillin | >256 | >256 | >256 | 8 | >256 |
Piperacillin | >256 | >256 | >256 | 1.5 | >256 |
Piperacillin + tazobactam | 32->256 | >256 | >256 | 1.5 | 16 |
Cefoxitin | 6-48 | >256 | 128 | 2 | 8 |
Ceftazidime | 16-128 | >256 | >256 | 0.5 | 24 |
Ceftazidime + clavulanate | 1.5-4 | >4 | >4 | 0.5 | 2 |
Cefotaxime | >256 | >256 | >256 | 0.19 | >256 |
Cefotaxime + calvulanate | 0.38-1 | >1 | >1 | <0.25 | 0.5 |
Cefepime | 32->256 | >256 | >256 | 0.125 | 128 |
Cefepime + clavulanate | 0.094-0.5 | >4 | >4 | 0.094 | 0.19 |
Aztreonam | 48->256 | >256 | >256 | 0.125 | >256 |
Imipenem | 0.38-0.5 | 8 | 12 | 0.38 | 0.38 |
Meropenem | 0.094-0.25 | 16 | 16 | 0.016 | 0.047 |
Ertapenem | 0.094-1.5 | >32 | >32 | 0.012 | 0.125 |
Gentamicin | 12-24 | 32 | 48 | 0.19 | 8 |
Tobramycin | 16-32 | 48 | 96 | 0.125 | 16 |
Amikacin | 1.5-3 | 3 | 6 | 0.75 | 0.75 |
Ciprofloxacin | >32 | >32 | >32 | 0.047 | 0.047 |
Trimethoprim + sulfamethoxazole | >32 | >32 | >32 | 0.012 | 0.032 |
Tetracyclines | >256 | >256 | >256 | >256 | >256 |
Range of MICs for five randomly selected isolates, each recovered from a different patient at different periods of the outbreak.